Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080.
Published February 14, 2018 · Recall initiated: January 19, 2018
Summary
FDA records drug Class III recall D-0250-2018, published February 14, 2018 and initiated January 19, 2018. Recalling firm: G & W Laboratories, Inc.; Status: Terminated; Reported quantity: 142,236 tubes; Lot: Lot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email if CICLOPIROX OLAMINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CICLOPIROX OLAMINE
- Manufacturer
- G & W Laboratories, Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- UPC
- 0307130638159
- Lot
- Lot #: a) 1002896, Exp 09/18; 1005797, Exp 05/19; 1006100, Exp 07/19; b) 1002561, Exp 06/18; 1002897, Exp 09/18; 1005798, Exp 05/19; 1006101, Exp 07/19; c) 1002898, Exp 10/18; 1004283, Exp 12/18; 1005837, Exp 05/19; 1006321, 1006322, Exp 07/19
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAll sterile drug preparations remaining within expiry prepared from Hydromorphone Base Solution dispensedFebruary 14, 2018
- FDAAll sterile drug preparations remaining within expiry prepared from Morphine Sulfate PF Base SolutionFebruary 14, 2018
- FDASyngo.plaza Picture Archiving and Communication System (PACS) with software version VB20A; Model numbers:February 7, 2018
- FDAAffixus Hip Fracture Nail, RH 130 DEG 9MM X 340MMFebruary 7, 2018
- FDAAffixus Hip Fracture Nail, RH 130 DEG 9MM X 320MMFebruary 7, 2018
- FDACiclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15), b) 30 g tubes (NDCApril 12, 2017
Questions about this recall
Was Ciclopirox Olamine Cream USP, 0.77%, packaged in a) 15 g tubes (NDC 0713-0638-15); b) 30 g tubes (NDC 0713-0638-31); and c) 90 g tubes (NDC 0713-0638-18), Rx Only, Manufactured by: G&W Laboratories, Inc., South Plainfield, NJ 07080. recalled?
Yes. FDA published recall D-0250-2018 on February 14, 2018. Reported hazard: Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CICLOPIROX OLAMINE. UPC: 0307130638159.